Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Founded in 1996, Albion Capital Group LLP is a London-based venture capital firm managing approximately £1 billion in assets. The firm focuses on early-stage investments across various sectors, including healthcare and frontier technologies. Albion has backed over 200 companies and achieved more than 100 IPOs and M&A exits.
Albion Capital invests in pre-seed to Series C stages, targeting sectors such as DeepTech, software, healthcare, and infrastructure. The firm emphasizes deeply technical, IP-rich opportunities with long-term growth potential, particularly in healthtech and life sciences. Albion aims to support visionary founders addressing significant global challenges through its investments.
Notable companies in Albion Capital's portfolio include Quantexa, a decision intelligence platform; Grapeshot, a contextual intelligence platform; Oviva, a digital health company; Phasecraft, specializing in quantum algorithms; Proveca, a pharmaceutical firm for children; and PSE, a provider of process modeling software.
Submit your pitch via email to Inquiries@albion.capital with your deck attached.
Yes, Albion Capital often leads investment rounds, particularly in early-stage companies where they can provide significant support and guidance.
Albion Capital is open to follow-on investments, especially for companies that demonstrate strong growth and alignment with their investment thesis.
Albion Capital manages approximately £1 billion in assets, allowing them to invest across various stages and sectors.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.